Baseline apelin levels were lower and NT pro-BNP levels higher iNT pro-BNP with AF compared to controlevels0 ± 186 vs 700 ± 151 pg/ml, p <0.001, and 615 ± 611 vs 50 ± 28 pg/ml, p <0.001, respectively).
In paired sera from HCV G2 (n = 13) and G3 (n = 20) patients, baseline sterol levels were lower in G3 than G2 for distal metabolites (7-dehyrocholesterol (7DHC) 0.017 versus 0.023 mg/dL; P adj) = 0.0524, cholesterol 140.9 versus 178.7 mg/dL; P adj) = 0.0242) but not the proximal metabolite lanosterol.
Baseline hemoglobin levels were lower in children than in adults, and decreased further at Day 3 (Table 6).
Unsurprisingly, baseline hemoglobin levels were lower in bleeding patients due to the severe blood loss incurred.
As expected, the baseline endotoxin levels were lower in the two trials enrolling patients with MRSA infections [ 8, 12].
Baseline VEGF levels were lower and showed a rapid increase during treatment in non-responders pts only while TSP1 levels did not change.
We also observed that baseline PSA levels were lower in control subjects carrying one or more minor alleles at the three highly correlated SNPs.
We show in this study for the first time that at baseline, FGF19 levels were lower in diabetic patients compared with nondiabetic control subjects, irrespective of BMI.
Although long-term studies will be required to confirm this observation, average baseline TG levels were lower than those cited above, leading us to conclude that this may have caused the change in HbA1c levels.
In women developing diabetes, baseline IGFBP1 levels were lower than expected for fasting insulin values, were associated with impaired suppression after OGTT and increased during 8 years despite an increase in fasting insulin.
